Based on these numbers, the researchers estimated that 5-year cumulative risks of recurrent events were 17.4% for ischemic ...

The annual risk of recurrent ischemic stroke in patients with atrial fibrillation (AF) is about 3.75%, despite around 92% of ...

Background Anticoagulation therapy reduces stroke risk in patients with atrial fibrillation (AF), but it is often underused in older populations due to concerns about bleeding. This study aimed to ...

Objectives To assess the risk of stroke/systemic embolism (SE) and major bleeding associated with the use of oral anticoagulants in elderly patients with atrial fibrillation (AF) in a real-world ...

Patients who had suspended anticoagulant therapy at least 24 hours before the ... Further research is needed to investigate mechanisms of recurrent stroke and improve secondary prevention in these ...

The REG1 anticoagulation system consists of intravenously administered RB006 and its matched, intravenously administered active control agent, RB007. 31 RB006 has a unique mechanism of action, ...

This is possible only with an understanding, even an incomplete one, of ketamine’s mechanism of action, she says: “ ‘Why’ is not trivial.” John Krystal of Yale University, whose work ...

Background: Coagulation disorders are common complications in patients with pulmonary infections. Studies have suggested beneficial effects of anticoagulant therapies in patients with COVID-19.

These findings suggest that SGLT2is might modulate the coagulation system to ultimately reduce thrombosis formation, possibly through the upregulation of endogenous anticoagulant mechanisms rather ...